![](/img/cover-not-exists.png)
High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission
Stein, A S, O’Donnell, M R, Slovak, M L, Nademanee, A, Dagis, A, Schmidt, G M, Parker, P M, Snyder, D S, Smith, E P, Somlo, GVolume:
14
Year:
2000
Language:
english
Pages:
6
DOI:
10.1038/sj.leu.2401839
File:
PDF, 95 KB
english, 2000